These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 6471935)

  • 1. Antioxidant therapy in neuronal ceroid-lipofuscinosis.
    Santavuori P; Westermarck T
    Med Biol; 1984; 62(2):152-3. PubMed ID: 6471935
    [No Abstract]   [Full Text] [Related]  

  • 2. Experience of antioxidant treatment in neuronal ceroid-lipofuscinosis of Spielmeyer-Sjögren type.
    Santavuori P; Moren R
    Neuropadiatrie; 1977 Nov; 8(4):333-44. PubMed ID: 579434
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Principles of antioxidant therapy in neuronal ceroid lipofuscinosis.
    Westermarck T; Santavuori P
    Med Biol; 1984; 62(2):148-51. PubMed ID: 6471934
    [No Abstract]   [Full Text] [Related]  

  • 4. Charting the effects of antioxidant therapy in the diseased brain: focus on "vitamin E deficiency and metabolic deficits in neuronal ceroid lipofuscinosis described by bioinformatics".
    Järvelä I; Glueck SB
    Physiol Genomics; 2002 Dec; 11(3):183-4. PubMed ID: 12464692
    [No Abstract]   [Full Text] [Related]  

  • 5. [Antioxidative therapy in ceroid lipofuscinosis].
    Rotteveel JJ; Mullaart RA
    Tijdschr Kindergeneeskd; 1989 Oct; 57(5):181-6. PubMed ID: 2815055
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Altered elemental profiles in neuronal ceroid lipofuscinosis.
    Johansson E; Lindh U; Westermarck T; Heiskala H; Santavuori P
    J Trace Elem Electrolytes Health Dis; 1990 Sep; 4(3):139-42. PubMed ID: 2136129
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Elemental profiles of blood cells in certain neurological disorders.
    Johansson E; Lindh U; Alanen T; Westermarck T; Heiskala H; Santavuori P; Elovaara I
    Med Biol; 1984; 62(2):139-42. PubMed ID: 6471932
    [No Abstract]   [Full Text] [Related]  

  • 8. English setter model and juvenile ceroid-lipofuscinosis in man.
    Koppang N
    Am J Med Genet; 1992 Feb; 42(4):599-604. PubMed ID: 1609842
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Neuronal ceroid-lipofuscinosis].
    Saitoh S
    Ryoikibetsu Shokogun Shirizu; 2001; (34 Pt 2):297-9. PubMed ID: 11528749
    [No Abstract]   [Full Text] [Related]  

  • 10. Late-infantile neuronal ceroid lipofuscinosis (CLN2/Jansky-Bielschowsky type) in Oman.
    Koul R; Al-Futaisi A; Ganesh A; Rangnath Bushnarmuth S
    J Child Neurol; 2007 May; 22(5):555-9. PubMed ID: 17690061
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of the clinical courses in patients with juvenile neuronal ceroid lipofuscinosis receiving antioxidant treatment and those without antioxidant treatment.
    Santavuori P; Heiskala H; Autti T; Johansson E; Westermarck T
    Adv Exp Med Biol; 1989; 266():273-82. PubMed ID: 2486154
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A casuistic rationale for the treatment of spastic and myocloni in a childhood neurodegenerative disease: neuronal ceroid lipofuscinosis of the type Jansky-Bielschowsky.
    Lorenz R
    Neuro Endocrinol Lett; 2002; 23(5-6):387-90. PubMed ID: 12500158
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Late infantile neuronal ceroid lipofuscinosis: a new mutation in Arabs.
    Goldberg-Stern H; Halevi A; Marom D; Straussberg R; Mimouni-Bloch A
    Pediatr Neurol; 2009 Oct; 41(4):297-300. PubMed ID: 19748052
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Variant late infantile neuronal ceroid lipofuscinosis (CLN6 gene) in Saudi Arabia.
    Al-Muhaizea MA; Al-Hassnan ZN; Chedrawi A
    Pediatr Neurol; 2009 Jul; 41(1):74-6. PubMed ID: 19520283
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Treatment of Sjogren's syndrome by traditional Chinese medicine (author's transl)].
    Zhang WZ
    Zhonghua Kou Qiang Ke Za Zhi; 1982; 17(1):51-3. PubMed ID: 6955158
    [No Abstract]   [Full Text] [Related]  

  • 16. Adult onset thalamocerebellar degeneration in dogs associated to neuronal storage of ceroid lipopigment.
    Sisó S; Navarro C; Hanzlícek D; Vandevelde M
    Acta Neuropathol; 2004 Nov; 108(5):386-92. PubMed ID: 15365721
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Free radicals, anticonvulsants, and the neuronal ceroid-lipofuscinoses.
    Maertens P; Dyken P; Graf W; Pippenger C; Chronister R; Shah A
    Am J Med Genet; 1995 Jun; 57(2):225-8. PubMed ID: 7668334
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Interest of prednisolone therapy in Sjögren's syndrome (author's transl)].
    Thomas M; Charpentier G; Hellenis P
    Therapie; 1981; 36(6):677-81. PubMed ID: 7342356
    [No Abstract]   [Full Text] [Related]  

  • 19. Melatonin ineffective in neuronal ceroid lipofuscinosis patients with fragmented or normal motor activity rhythms recorded by wrist actigraphy.
    Hätönen T; Kirveskari E; Heiskala H; Sainio K; Laakso ML; Santavuori P
    Mol Genet Metab; 1999 Apr; 66(4):401-6. PubMed ID: 10191137
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Sulfasalazine therapy for hypergammaglobulinemia in patients with Sjögren's syndrome].
    Imai F; Suzuki T; Ishibashi T; Ohno S; Tanaka M; Dohi Y
    Arerugi; 1994 Jan; 43(1):68-70. PubMed ID: 7908513
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.